What is William Blair’s Estimate for NMRA Q1 Earnings?
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Free Report) – Equities research analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of Neumora Therapeutics in a note issued to investors on Monday, March 3rd. William Blair analyst M. Minter anticipates that the company will post earnings per share of ($0.44) for […]
